Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 164 Lung Neoplasms 61 Small Cell Lung Carcinoma 24 Neoplasms 10 NSCLC 9 Mesothelioma, Malignant 9 Breast Neoplasms 8 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Melanoma 6 Head and Neck Neoplasms 6 Colorectal Neoplasms 6 Esophageal Neoplasms 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Mesothelioma 4 Kidney Neoplasms 4 Brain Neoplasms 4 Sarcoma 3 Pleural Effusion, Malignant 3 Liver Neoplasms 3 Fallopian Tube Neoplasms 3 Cholangiocarcinoma 3 Carcinoma 3 Adenocarcinoma of Lung 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Thymoma 2 Small Cell Lung Cancer Limited Stage 2 Skin Neoplasms 2

Interventions

pembrolizumab 2 toripalimab 1 sintilimab 1 pemigatinib 1 osimertinib 1 durvalumab 1 Vinorelbine 1 Platinum Compounds 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × Drug Therapy × Thoracic × Clear all

NCT03351361 2023-03-01

eNERGY

Rennes University Hospital

Phase 3 Completed

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡